Skip to main content
. 2022 Aug 24;14(17):4103. doi: 10.3390/cancers14174103

Table 4.

Rates of KRAS mutations in lung AC subdivided in different ethnicities.

KRAS Mutation Rates
Caucasians Asians Africans Americans
KRAS exon2
c.34G > T (p.G12C) 34% 24.5% NA 41.2%
c.35G > T (p.G12V) 21% 1.5% NA 19%
c.35G > A (p.G12D) 14% 25.5% 28.5% 15%
c.35G > C (p.G12A) 9.5% 1.3% NA 7%
c.34G > A (p.G12S) 1% 0.6% NA 1%
c.34G > C (p.G12R) 1% 0.6% NA 1%
c.37G > T (p.G13C) 4% 0.7% NA 7%
c.38G > A (p.G13D) 1–2% 0.7% 42.8% 1%
c.37G > C (p.G13R) 0.5% 0.5% NA 0.5%
c.37G > A (p.G13S) NR NR NR NR
KRAS exon3
c.183A > C (p.Q61H) 1% 0.8% NA 4%
c.182A > T (p.Q61L) 0.5% 0.4% NA 1%
c.182A > G (p.Q61R) 0.06% 0.05% NA 0.05
c.180_181delinsAA (p.Q61K) 0.02% NR NA 0.02
c.181C > G (p.Q61E) NR NR NA NR
c.176C > A (p.A59E) NR NR NA NR
c.176C > G (p.A59G) NR NR NA NR
c.175G > A (p.A59T) NR NR NA NR
KRAS exon4 NR NR NA NR
c.436G > C (p.A146P) NR NR NA NR
c.436G > A (p.A146T) NR NR NA NR
c.437C > T (p.A146V) NR NR NA NR

AC, AdenoCarcinoma; NA: Not Available; NR: Not Relevant (Boch et al., 2013 [19]; Elghissassi et al., 2014 [31]; Kim et al., 2014 [32]; Li et al., 2014 [33]; Nadal et al., 2014 [34]; Arrieta and Ramírez-Tirado et al., 2015 [35]; Dhieb et al., 2019 [36]; Judd et al., 2021 [18]).